TherapeuticsMD (TXMD) Cash from Financing Activities (2011 - 2023)
TherapeuticsMD's Cash from Financing Activities came in at $2 million for Q4 2023, compared with -$111.95 million a year earlier.
Powered by 
Analysis
TherapeuticsMD (TXMD) Cash from Financing Activities (2011 - 2023) Analysis & Trends
For FY2023, TherapeuticsMD's Cash from Financing Activities was $3.15 million.
- Cash from Financing Activities carries a five-year compound annual growth rate of -54.6% (FY2018 to FY2023).
- Going back by year, Cash from Financing Activities was -$235.21 million in FY2022, $129.55 million in FY2021 (+60.5%), $80.73 million in FY2020 (-57.2%) and $188.83 million in FY2019 (+16.0%).
- The Q4 2023 figure represents the highest quarterly Cash from Financing Activities since Q3 2021.
- The fastest year-over-year change in Cash from Financing Activities over five years came in Q2 2021 (growth of 355.3%), and the weakest in Q3 2019 (a decline of 100.0%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,164.71 Bn | 1,133.30 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 633.37 Bn | 551.90 Bn | 17.26 Bn | -8.78 Bn |
| 3 | AbbVie | 503.99 Bn | 477.10 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 378.19 Bn | 332.57 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 303.15 Bn | 267.14 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 266.17 Bn | 239.85 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 241.38 Bn | 196.78 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 194.07 Bn | 168.27 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 172.31 Bn | 118.96 Bn | 10.94 Bn | -3.66 Bn |
| 10 | TherapeuticsMD | 21.69 Mn | 21.69 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 2.00 Mn |
| Sep 30, 2023 | -1,000.00 |
| Dec 31, 2022 | -111.95 Mn |
| Sep 30, 2022 | 1.74 Mn |
| Jun 30, 2022 | -120.00 Mn |
| Mar 31, 2022 | -5.00 Mn |
| Dec 31, 2021 | 1.35 Mn |
| Sep 30, 2021 | 31.82 Mn |
| Jun 30, 2021 | 428,000.00 |
| Mar 31, 2021 | 95.95 Mn |
| Dec 31, 2020 | 31.70 Mn |
| Sep 30, 2020 | 106,000.00 |
| Jun 30, 2020 | 94,000.00 |
| Mar 31, 2020 | 48.82 Mn |
| Dec 31, 2019 | 77.03 Mn |
| Sep 30, 2019 | 8,549.00 |
| Jun 30, 2019 | 111.69 Mn |
| Mar 31, 2019 | 100,107.00 |
| Dec 31, 2018 | 429,895.00 |
| Sep 30, 2018 | 90.02 Mn |
API Access
TherapeuticsMD Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();